• Regulatory NewsRegulatory News

    FDA Announces a Secretive Meeting to Discuss an Unknown Drug for Unknown Reasons

    The US Food and Drug Administration (FDA) regularly convenes panels of its various Advisory Committees to offer the agency advice on a wide range of regulatory topics—everything from general policy recommendations to specific advice on a particular drug or drug class. In general, those panels—and the advice they dispense—is open to the public. For example, per 21 CFR 314.430(d) , most drug products being assessed by FDA's advisory committees are open to the public and a...